Sign in

CIK 0001314102

  • Non-accelerated filer
  • Smaller reporting company

EyePoint, Inc.

Sign in to watch
Ticker
EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262774444
Phone
+1 617-926-5000
Business address
480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-09 Elston George Chief Financial Officer Option exercise +5,833 18,149
2023-02-09 Elston George Chief Financial Officer Option exercise +4,967 23,116
2023-02-09 Elston George Chief Financial Officer Option exercise · Restricted Stock Units −5,833 11,667
2023-02-09 Elston George Chief Financial Officer Option exercise · Restricted Stock Units −4,967 4,967
2023-02-09 Lurker Nancy CEO Option exercise +17,533 170,559
2023-02-09 Lurker Nancy CEO Option exercise +20,000 190,559
2023-02-09 Lurker Nancy CEO Option exercise · Restricted Stock Units −20,000 40,000
2023-02-09 Lurker Nancy CEO Option exercise · Restricted Stock Units −17,533 17,534
2023-01-06 Lurker Nancy CEO Grant or award · Stock Option (Right to Buy) +450,800 450,800
2023-01-06 Duker Jay S. President and COO Grant or award · Stock Option (Right to Buy) +124,755 124,755
2023-01-06 Elston George Chief Financial Officer Grant or award · Stock Option (Right to Buy) +91,655 91,655
2023-01-06 Jones David Scott SVP & Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +91,655 91,655
2023-01-06 Pine Michael Craig Chief Corp Dev.&Strat. Officer Grant or award · Stock Option (Right to Buy) +91,655 91,655
2023-01-06 Paggiarino Dario A. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +91,655 91,655
2022-11-01 Duker Jay S. Chief Operating Officer Option exercise +15,258 25,881
2022-11-01 Duker Jay S. Chief Operating Officer Shares withheld for taxes −4,479 $5.42 $24K 21,402
2022-11-01 Duker Jay S. Chief Operating Officer Option exercise · Restricted Stock Units −15,258 0
2022-09-07 Duker Jay S. Chief Operating Officer Grant or award · Stock Option (Right to Buy) +65,300 65,300
2022-07-11 Zaderej Karen L. Director Grant or award · Restricted Stock Units +6,000 6,000
2022-07-11 Zaderej Karen L. Director Grant or award · Stock Option (Right to Buy) +22,000 22,000

Page 26 of 31 · 616 trades